Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system
β Scribed by Paola Devoto; Maria Collu; Anna Lisa Muntoni; Marco Pistis; Gino Serra; Gian Luigi Gessa; Marco Diana
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 288 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0887-4476
No coin nor oath required. For personal study only.
β¦ Synopsis
Systemic administration of the putative selective D, receptor agonist 7-hydroxy-2-(N,N-di-n-propylamino)tetralin (7-OH-DPAT) consistently decreased extracellular dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) levels in the nucleus accumbens and dopaminergic neuronal activity in the ventral tegmental area. 7-OH-DPAT inhibited dopamine release in the nucleus accumbens also when locally perfused through the dialysis probe. The results suggest the possibility that stimulation of dopamine D, receptors with 7-OH-DPAT mimic biochemical and electrophysiological actions previously ascribed to D, autoreceptor stimulation; however the lack of selective D, antagonist precludes any firm conclusion in this sense. o 1995 Wiley-Liss, Inc.
π SIMILAR VOLUMES
The effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by the 5-HT~A receptor agonist, 8-hydroxy-2-(di-npropylamino) tetralin (8-OH-DPAT), were examined. Gepirone dose-dependently increased feeding 2 and 4 h after injection, the magnitude of th
TaiCatoxin (TCX), a complex toxin isolated from Taipan snake venom, is believed to have a specific blocking activity on voltage-dependent cardiac calcium channels. The aim of this study was to investigate the effects of TCX on a broad range of heart muscle cell functions, i.e. electrophysiology, con
It has been established that administration of agonists attenuates the 5-HT 1A rate of isolation-induced ultrasonic vocalizations (USV) in 10-day-old rat pups. In this study we extended these findings by examining the effects of administration of the serotonergic 1A receptor agonist, 8-hydroxy-2-(di